✦ LIBER ✦

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

✍ Scribed by Stephen B. Hanauer; William J. Sandborn; Paul Rutgeerts; Richard N. Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul Pollack

Book ID: 118734536
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 356 KB
Volume: 130
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2005.11.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CDP571, a humanized anti-tumor necrosis

CDP571, a humanized anti-tumor necrosis factor-α monoclonal antibody in pediatric Crohn's disease

✍ Petar Mamula; Stanley A. Cohen; George D. Ferry; Barbara S. Kirschner; Harland S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

A controlled trial of anti-tumor necrosi

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease

✍ WJ Sandborn 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Adalimumab, a fully human anti–tumor nec

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

✍ Michael E. Weinblatt; Edward C. Keystone; Daniel E. Furst; Larry W. Moreland; Mi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Endoscopic and histological healing with

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

✍ Geert D'Haens*; Sander Van Deventer‡; Ruud Van Hogezand §; Douglas Chalmers∥; Ch 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Anti-tumor necrosis factor treatment res

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease

✍ Peter Suenaert; Veerle Bulteel; Liesbeth Lemmens; Maja Noman; Benny Geypens; Ger 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Guillain–Barrè syndrome after treatment

Guillain–Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: Case report and literature review

✍ Monica Cesarini; Erika Angelucci; Tiziana Foglietta; Piero Vernia 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 175 KB